Article
Magnetic Resonance Imaging to Detect Early Molecular and Cellular Changes in Alzheimer's Disease
16 Jun 2016
Abstract excerpt
Recent pharmaceutical trials have demonstrated that slowing or reversing pathology in Alzheimer's disease is likely to be possible only in the earliest stages of disease, perhaps even before significant symptoms develop. Pathology in Alzheimer's disease accumulates for well over a decade before symptoms are detected giving a large potential window of opportunity for intervention. It is therefore important that...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
